Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf ·...
Transcript of Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf ·...
![Page 1: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/1.jpg)
Molecular mechanisms of disease
Relating genotype and pathology
Peter K. Rogan, Ph.D.Laboratory of Human Molecular GeneticsChildren’s Mercy Hospital and ClinicsUniversity of Missouri-Kansas City School of Medicinehttp://www.sce.umkc.edu/~roganp
![Page 2: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/2.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Functional classes of proteins and example disorders
• Enzymes– amino acids (PKU), carbohydrates (galactosemia), organic acids (MM-
CoA mutase), lipids, purines (ADA, Lesh Nyhan), porphyrins (AIP)• Transport
– interorgan (Hb), organelle membrane, intracellular transport (Menkes), epithelial membrane (CF)
• Structural– extracellular (OI), cell membrane struct (spherocytosis, DMD), organelle
(Zellweger: peroxisome biogenesis)• Extracellular homeostatis
– immune, hemostasis (hemophilia), protease inhibition (AAT deficiency)
![Page 3: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/3.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Functional classes of proteins(continued)
• Control of growth and differentiation– tumor suppressors (retinoblastoma/osteosarcoma), proto-oncogenes
(leukemia, other tumors)• Intercellular metabolism and communication
– Light receptors (RP, color blindness), hormones (dwarfism), hormone receptors (rickets, AR: testicular feminization), signal transducers (pseudohypoparathyroidism: hypocalcemia and hyperphosphatemia), metabolite
receptors (hypercholesterolemia)
![Page 4: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/4.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Outline of pathogenetic mechanisms
![Page 5: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/5.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Enzyme deficiencies & disease• Almost all recessive. Many enzymes can maintain normal
substrate and product levels with Vmax<10% normal• Pathophysiology due either to accumulation of substrate,
deficiency of product, or both• If substrate is macromolecule, pathology confined to tissue
where it accumulates. If diffusable substrate, multisysteminvolvement more likely.
• Multienzyme deficiency results from cofactor defect, they share common subunit, or if the cellular compartment defective.
• Phenotypic homology: diseases of other enzymes in same area of metabolism, or partial vs. complete deficiencies at same locus.
![Page 6: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/6.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Mutations altering gene expression: thalassemia vs. hereditary persistence of fetal hemoglobin
HbF HbA2 HbA
Adult beta globin -, fetal beta globin -
Adult beta globin -, fetal beta globin +
Deletion mapping of mutations in beta globin gene cluster
![Page 7: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/7.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Mutations altering protein synthesis: acute intermittent porphyria
Increase synthesis of cytochromes 450. Lowers heme levels, alleviates feedback inhibition on ALAsynthesis. Excess ALA&PBG produces peripheral, autonomic, and CNS phenotype.
LEVEL:
![Page 8: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/8.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Mutations impairing cofactor bindingHomocystinuria
Pyridoxal phosphate binding (pyridoxine)
Recessive: ectopia lensis, MR,osteoporesis, lengthening/thinning bones,thromboembolism of veins and arteries
Defects in cytosoliccobalamin metabolism,or in methylcobalaminsynthesis (vitamin B12)
(folate)
![Page 9: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/9.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Abnormal stochiometry - mild
![Page 10: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/10.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Macromolecular assembly(dominant negative mutation)
![Page 11: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/11.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Macromolecular assembly(dominant negative α1 mutation)
![Page 12: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/12.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
![Page 13: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/13.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Protein modification: Ehlers-Danlossyndrome Type VI
Caused by lysyl hydroxylase deficiency, which catalyzes posttranslational modification of collagen I and III chains. Modificationreq’d for intermolecular crosslinks to stabilize collagen fibrills.
![Page 14: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/14.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Incorrect subcellular localization:methymalonic aciduria
Most mutations in MM-CoAstructural gene or formationof adensylcobalamin (cofactor)are clinically heterogeneous.
Phenotype: Metabolic acidosis. Severely affected patients are lethargic, fail to thrive and have recurrentemessis.
![Page 15: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/15.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Mutations affecting protein degradation: G6PD A- (VAL68MET, ASN126ASP, XR)
• G6PD deficiency phenotype: severe chronic granulomatous disease from neutrophil dysfunction, hemolytic anemia, splenomegaly
• High freq. in Africans, Mediterraneans and Asians, heterozygote advantage viz-a-viz malaria
• G6PD critical for NADPH regeneration, essential for protection against and repair of oxid. damage. G6PD- red cells are more sensitive to hydrogen peroxide generated by the malaria parasite, making them a poor host.
• Instability of the mutant enzyme results from protein degradation (4% yield), not decreased activity.
![Page 16: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/16.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
![Page 17: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/17.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Milder phenotype- partial expression of beta globin
Beta-0: failure to thrive, jaundice,hepatosplenomegaly, skeletal changes,hypochromic RBC. Req transfusion
Beta-+: hypochromic, microcytic RBCMisdiagnosed as Iron deficiency.
![Page 18: Relating genotype and pathologyacademic.cytognomix.com/Course/Pathogeneticslecture.pdf · structural gene or formation of adensylcobalamin (cofactor) are clinically heterogeneous.](https://reader030.fdocuments.in/reader030/viewer/2022011815/5e66d5da357e821d1b72dced/html5/thumbnails/18.jpg)
Peter K. Rogan,Ph.D. Molecular Mechanisms of Disease-pathogenetics
Summary: Molecular pathology and phenotype
• Different mutations in a single gene may produce very different clinical phenotypes.Variation in clinical presentation reflects specific property
of protein that has been perturbed. Example: thalassemia versus methemoglobinemia.
• The biochemical and clinical consequences of a mutation are often unpredictable.
Examples: HbS and sickling, PKU and MR, Rhodopsinand degenerative RP